Home/Filings/4/0001171843-17-007015
4//SEC Filing

Delaney Brendan 4

Accession 0001171843-17-007015

CIK 0000722830other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:39 PM ET

Size

5.4 KB

Accession

0001171843-17-007015

Insider Transaction Report

Form 4
Period: 2017-11-10
Delaney Brendan
Chief Commercial Officer
Transactions
  • Award

    Stock Options (right to buy)

    2017-11-10+150,000150,000 total
    Exercise: $12.40Exp: 2024-11-10Common Stock, par value $0.01 per share (150,000 underlying)
Footnotes (1)
  • [F1]The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter.

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeother

Related Parties

1
  • filerCIK 0001722585

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:39 PM ET
Size
5.4 KB